Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06480760
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 120 participants
- Registry
-
NCT06480760
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06480760. Randomized; triple masking; primary purpose treatment. Start 2025-05-20 (actual); primary completion 2028-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
- Acronym
- CIPHER
- Condition
- Peripheral Arterial Disease
- Intervention (Drug)
- Carnosine
- Lead sponsor
- Shahid Baba
- Collaborator
- National Institutes of Health (NIH)
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct06480760- Content hash
0dd365df1d0abd9a239d4f7977f792f26e7a22113b341a11814d7bb75665ded7